ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

brivaracetam

Also written as “Brivaracetam”, “Brivaracetam Film-coated tablet” and “Brivaracetam oral solution”.

Its studies are mostly in Epilepsy · Epilepsy, Absence · Epilepsies, Partial · Myoclonus · Seizures, led by 4 companies.

Drug pageBrivaracetam: every studyAll 48 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Sep 6, 200542 company-led studies, 3 open or runningNext primary completion: Nov 16, 2029 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
UCB392 open or runningphase 3since Sep 6, 2005Sep 6, 2005Nov 16, 2029phase 3 · NCT06315322
Overseas Pharmaceuticalsits history only10 open or runningphase 1since Nov 11, 2022Nov 11, 2022none ahead
Qingfeng Pharmaceutical Groupits history only10 open or runningphase 3since Apr 17, 2026Apr 17, 2026none ahead
Sino Biopharmaceuticalits history only11 open or runningphase 1since Dec 23, 2024Dec 23, 2024none ahead

Also a collaborator on its studies: PRA Health Sciences.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of UCB only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 25 studies since Sep 6, 2005.

  1. Nov 6, 2015Phase 1 study in Healthy VolunteersNCT02602860 · 13 enrolled · United States
  2. Jan 11, 2017Phase 2 study in EpilepsyNCT03021018 · 46 enrolled · United States
  3. Feb 28, 2017Phase 3 study in EpilepsyNCT03083665 · 449 enrolled · China, Japan, Malaysia and more
  4. Jul 31, 2017Phase 3 study in EpilepsyNCT03250377 · 207 enrolled · China, Japan
  5. Oct 25, 2017Phase 3 study in EpilepsyNCT03325439 · 9 enrolled · Belgium, Czechia, France and more
  6. Jan 12, 2018Phase 2 study in EpilepsyNCT03405714 · 50 enrolled · United States, Czechia, Germany and more
  7. Sep 20, 2018Phase 3 study in EpilepsyNCT03685630 · 10 enrolled · Japan
  8. Dec 7, 2020Phase 3 study in Epilepsy, AbsenceNCT04666610 · 154 enrolled · United States, Georgia, Italy and more
  9. Jan 14, 2021Phase 3 study in EpilepsyNCT04715646 · 84 enrolled · United States, Hungary, Italy and more
  10. May 6, 2021Phase 1 study in EpilepsyNCT04882540 · 12 enrolled · China
  11. Oct 25, 2021Phase 3 study in Epilepsy, AbsenceNCT05109234 · 84 enrolled · United States, Georgia, Italy and more
  12. Mar 14, 2022Phase 1 study in Healthy Study ParticipantsNCT05315947 · 24 enrolled · Japan
  13. Mar 8, 2024Phase 1 study in Healthy Study ParticipantsNCT06312566 · 64 enrolled · Japan
  14. Mar 11, 2024Phase 3 study in Epilepsy, AbsenceNCT06315322 · 70 enrolled · United States, Georgia, Italy and more

Ahead

  1. Nov 16, 2029Primary completion: phase 3 study in Epilepsy, AbsenceNCT06315322
  2. Jul 8, 2030Primary completion: phase 3 study in EpilepsyNCT04715646

TargetBeta

SV2A →read by rule
“Synaptic vesicle glycoprotein 2A modulator”ChEMBL 37, by rule

Other programs on SV2A

ProgramCompanyFurthest phaseStudies
LevetiracetamruleUCBphase 473

Studies

All 39 UCB leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06315322Epilepsy, Absence · United States, Georgia, Italy and more3Active, not recruitingNov 16, 202970
NCT06312566Healthy Study Participants · Japan1CompletedJun 4, 202464
NCT05315947Healthy Study Participants · Japan1CompletedMay 13, 202224
NCT05109234Epilepsy, Absence · United States, Georgia, Italy and more3CompletedMar 18, 202584
NCT04882540Epilepsy · China1CompletedJun 8, 202112
NCT04715646Epilepsy · United States, Hungary, Italy and more3Active, not recruitingJul 8, 203084
NCT04666610Epilepsy, Absence · United States, Georgia, Italy and more3CompletedJul 7, 2026154
NCT03685630Epilepsy · Japan3CompletedMar 27, 202110
NCT03405714Epilepsy · United States, Czechia, Germany and more2CompletedNov 4, 202050
NCT03325439Epilepsy · Belgium, Czechia, France and more3TerminatedSep 3, 20209
NCT03250377Epilepsy · China, Japan3CompletedDec 24, 2024207
NCT03083665Epilepsy · China, Japan, Malaysia and more3CompletedJun 30, 2022449
NCT03021018Epilepsy · United States2CompletedApr 27, 201846
NCT02602860Healthy Volunteers · United States1CompletedSep 201713
NCT02088957Nonconvulsive Electrographic Seizures · United States2TerminatedOct 20141
NCT01728077Epilepsy · United States, France, Germany and more3CompletedAug 201626
NCT01710670Healthy Volunteers · Netherlands1CompletedNov 201218
NCT01653262Epilepsy · United States, France, Germany and more3CompletedNov 201329
NCT01405508Epilepsy · United States, Czechia, Germany and more3CompletedJul 2012105
NCT01364597Epilepsy · United States, Belgium, Czechia and more3CompletedFeb 3, 2022257
NCT01339559Epilepsy · United States, Austria, Belgium and more3CompletedApr 18, 2019767
NCT01261325Epilepsy · United States, Austria, Belgium and more3CompletedMay 2014768
NCT00761774Epilepsy · United States, Australia, Belgium and more3CompletedMar 2017108
NCT00736931Epilepsy · United States1CompletedOct 200820
NCT00699283Epilepsy · United States, France, Germany and more3TerminatedMar 201062
NCT00698581Epilepsy · United States, Australia, Belgium and more3TerminatedJan 201088
NCT00504881Epilepsy · Austria, Belgium, Czechia and more3CompletedNov 2008480
NCT00490035Epilepsy · Belgium, Finland, France and more3CompletedFeb 2009399
NCT00464269Epilepsy · United States, Australia, Brazil and more3CompletedDec 2008400
NCT00426673Epilepsy · United States1CompletedJun 200615
NCT00422422Epilepsy · United States, Belgium, Czechia and more2CompletedMar 2013100
NCT00401648Epilepsy · France, Germany2CompletedJun 200320
NCT00368251Unverricht-Lundborg Syndrome · United States, Canada, Finland and more3CompletedJan 200856
NCT00357669Unverricht-Lundborg Syndrome · Finland, France, Italy and more3CompletedOct 200750
NCT00175929Epilepsies, Partial · Belgium, Czech Republic, Finland and more2CompletedMar 2006157
NCT00175916Epilepsy · United States, Austria, Belgium and more3CompletedMay 2019853
NCT00175825Epilepsy · United States, Brazil, India and more2CompletedJun 29, 2006210
NCT00160667Neuralgia, Postherpetic · Belgium, Bulgaria, Czechia and more2CompletedJan 5, 2006152
NCT00150800Epilepsy · United States, Australia, Brazil and more3CompletedSep 2017668

How it is read

Names in the registry

  • “Brivaracetam”, 33 entries
  • “brivaracetam”, 3 entries
  • “Brivaracetam Film-coated tablet”, 2 entries
  • “Brivaracetam oral solution”, 2 entries
  • “Brivaracetam 25 mg”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.